Israel Englander Aravive, Inc. Transaction History

Millennium Management LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.25 - $1.92 $319,950 - $491,443	-255,960 Reduced 69.34%	113,160 $142,000
Q1 2023 May 15, 2023	BUY	$1.29 - $2.46 $389,647 - $743,047	302,052 Added 450.37%	369,120 $738,000
Q4 2022 Feb 14, 2023	BUY	$1.2 - $1.83 $27,618 - $42,117	23,015 Added 52.24%	67,068 $89,000
Q3 2022 Nov 14, 2022	SELL	$0.61 - $1.03 $32,198 - $54,368	-52,785 Reduced 54.51%	44,053 $36,000
Q2 2022 Aug 15, 2022	BUY	$0.93 - $1.9 $33,387 - $68,210	35,900 Added 58.91%	96,838 $96,000
Q1 2022 May 16, 2022	SELL	$1.85 - $2.75 $89,638 - $133,245	-48,453 Reduced 44.29%	60,938 $118,000
Q4 2021 Feb 14, 2022	BUY	$2.19 - $4.07 $50,302 - $93,483	22,969 Added 26.58%	109,391 $240,000
Q3 2021 Nov 15, 2021	SELL	$3.67 - $5.8 $20,640 - $32,619	-5,624 Reduced 6.11%	86,422 $321,000
Q2 2021 Aug 16, 2021	BUY	$4.65 - $6.42 $251,741 - $347,565	54,138 Added 142.81%	92,046 $550,000
Q1 2021 May 17, 2021	BUY	$5.11 - $9.24 $193,709 - $350,269	37,908 New	37,908 $250,000
Q4 2020 Feb 16, 2021	SELL	$4.36 - $6.51 $116,970 - $174,650	-26,828 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.7 - $12.06 $126,091 - $323,545	26,828 New	26,828 $126,000
Q2 2020 Aug 14, 2020	SELL	$5.18 - $14.81 $292,514 - $836,320	-56,470 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$3.5 - $13.77 $197,645 - $777,591	56,470 New	56,470 $325,000
Q1 2019 May 14, 2019	SELL	$3.35 - $8.27 $82,138 - $202,772	-24,519 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.23 - $8.7 $79,196 - $213,315	24,519 New	24,519 $86,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.